Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

The FDA sent out "100 cease-and-desist letters" to brands in response to what it says is "deceptive" pharma advertising - ...

A federal appeals court on Thursday rejected Eli Lilly’s appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Weight-loss drugs have made headlines with famous names, like tennis superstar Serena Williams, admitting to taking them and ...

Working-age Americans who get health insurance through their job will see largest health insurance rate hikes since 2010.

The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Nature’s Way has launched a new line of fruit-flavored drink mixes that aim to support weight wellness. Weight Manager, ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s Zepbound, so too — frustratingly — do the barriers to accessing them.

Novo Nordisk › Finding undervalued stocks isn't easy these days. The average stock price for companies in the benchmark S&P ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...